Renal exam - clinical Flashcards
(163 cards)
recommendation for BP in elevated range
nonpharmacologic therapy with reassessment in 3-6 months
recommendation for stage 1 HTN and ASCVD risk < 10%
nonpharmacologic therapy with reassessment
recommendation for stage 1 HTN and ASCVD risk > 10%
start meds
recommendation for stage 2 HTN
start meds
1st line HTN drug categories
thiazides, CCBs, ACEIs, ARBs
thiazide prototype
HCTZ, chlorthalidone
CCB prototypes
amlodipine, clevidipine
ACEI prototype
captopril
ARB prototype
losartan
thiazides mechanism
block Na/Cl cotransporter in DCT
thiazides side effects
hypokalemia, increase in glucose, lipids, uricemia, calcium.
ACEI/ARB side effects
cough (ACE only), angioedema, teratogen, increased creatinine, hyperkalemia, hypotension (CATCHH)
special ACEI/ARB indication
first choice for patients with DM, CKD, CHF
drugs for HTN in pregnancy
Nifedipine, methyldopa, labetalol, hydralazine (new moms love hugs)
drugs for HTN with heart failure
diuretics, ACEIs/ARBs, beta blockers, aldosterone antagonists
drugs for HTN with DM
ACEIs/ARBs, CCBs, thiazides, beta blockers
consideration of BBs in DM
BBs can mask ssx of hypoglycemia
specific drug for HTN with CHF
vaslartan-sacubitril
prototype alpha-1 blocker
prazosin
prototype alpha-2 agonist
clonidine
mechanism of beta blockers
decrease cardiac output and renin release. Also decrease peripheral resistance if combined with vasodilating agent (labetalol)
mechanism of alpha 2 agonists
sensitize brainstem to inhibition by baroreceptor reflexes
hypertensive urgency
asymptomatic, >180/>120
hypertensive emergency
severe HTN associated with end-organ damage